I'll be joining. I have a considerable holding and I will be dumping the entire lot on any positive update. This pandemic has exposed imm for what it really is. The silence from the company in these times is very telling.
One thing covid has exposed is just how much imm are a one trick pony. The total silence on any significant project update around their other assets is concerning me. It's nearly a year since the avion agreement was signed and we were promised a news rich period which just hasn't transpired. It shows just how much that news rich period was about lupuzor. After holding here for 7 years as soon as this gets to 20p I'll break even and I'll be gone. I will return only on the build up on the next ph3 results but holding in between is a waste of time.
Thanks for the rns about another company. So the news flow on immupharmas pipeline, partnerships, jv, ph3, product updates..... that we were promised back in q1. Where are those?
Also now the statement says "Still expect to have enough funding to the end 2023" that is not the same as we are still funded to the end of 2023. Watch out here.
Held these for years and had pretty much given up on them. Checked in this morning and was surprised to see the rise. Im still a way from recovering my losses but can anyone explain what's going on? Thanks all